- Correspondence to Dr Emmanuel Monnet, Clinical Development, NovImmune SA, Geneva, Plan les Ouates 1228, Switzerland;
- Received October 16, 2019
- Revised December 3, 2019
- Accepted December 13, 2019
- First published December 31, 2019.
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.